Clinical Trial Update: Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating the pharmacokinetics, efficacy, and safety of olokizumab in patients with Juvenile idiopathic arthritis; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Olokizumab (olokizumab)

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Juvenile Idiopathic Arthritis | Phase 2 | Status: RECRUITING